Lineus Medical and New England Medical Specialties Announce Partnership NEMS to Distribute SafeBreak® Vascular in New England
ncarol.com/10150542

FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network into the Northeast with the signing of New England Medical Specialties. NEMS specialize in products for I.V. Therapy, vascular access, oncology, and fall prevention. Their sales team covers Vermont, New Hampshire, Massachusetts, Rhode Island, Connecticut, and New York on behalf of Lineus Medical.

"New England Medical Specialties has provided innovative medical device solutions to our customers for over 35 years." said NEMS President Bob Proietto. "We specialize in I.V. therapy and vascular access and know that SafeBreak Vascular is going to be an important part of our product portfolio. SafeBreak Vascular is an innovative product, and we are known for bringing new technologies to the marketplace."

Lineus Medical CEO, Vance Clement, added, "When partnering with medical device distributors, we work with the best. New England Medical Specialties is the leader in their area of the country, and we are thrilled to have them represent us. Our flagship product, SafeBreak Vascular, was proven to reduce IV complications requiring an IV restart by 44% in a randomized clinical study in Hartford, CT¹. Having a study conducted in New England is an impactful starting point for Bob Proietto and his team."

More on ncarol.com

• Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
• ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
• New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
• Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
• Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free

SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world. The device is designed to separate when damaging force is placed on an IV line, reducing vein irritation and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient.

SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually².

ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other  medical tubing may be reduced when a force-activated separation device is used. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.

More on ncarol.com

• Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
• PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
• Tonight in Asheville: KayeDinero Drops "Underground" and Opens Beat Catalog
• KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
• Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)

¹D.I.P.P.E.R Study - Data on file.
²Data on file.
³Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203

MKG-0122 Rev 0